Severity
Moderate
FDA Devices recall · Reported July 3, 2019
The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
AtriCure, Inc. recalled EPi-Sense Guided Coagulation System with Visitrax, MOdel No. CDK-1413 - Product Usage: Th… - a moderate-severity action.
EPi-Sense Guided Coagulation System with Visitrax, MOdel No. CDK-1413 - Product Usage: Th… was recalled by AtriCure, Inc. in July 3, 2019. Reason: The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case…. Check the official notice for the remedy. Verify recall #Z-1887-2019 with the FDA Devices before acting.
The recall
AtriCure, Inc. issued this moderate-severity FDA Devices recall-The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case….
Sourced from official FDA Devices enforcement records. Verify recall #Z-1887-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1887-2019) was formally reported on July 3, 2019, with the manufacturer initiating the action on May 29, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. AtriCure, Inc. is listed as the recalling firm, operating out of Mason, OH. Federal records list the affected scope as 497.
The documented reason for this recall is: The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used. Distribution data in the federal record shows the product reached: Worldwide distribution - US Nationwide distribution, and countries of Germany and Netherlands.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,861 medical devices recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
497
Related Recalls
6
6 from same agency
EPi-Sense Guided Coagulation System with Visitrax, MOdel No. CDK-1413 - Product Usage: The EPi-Sense Guided Coagulation System with VisiTrax, consists of a sterile, single-use, disposable coagulation electrode device (1cm, 2cm, and 3cm sizes provided) intended to be used to coagulate cardiac tissue. The flexible, cooled electrode device, with a suction stabilizer feature, transmits radiofrequency (RF) energy from an Electrosurgical Generator (non-sterile, re-useable) connected through an Instrument Cable (sterile). A temporary sensing electrode feature may be used with an off-the-shelf electrogram recording system with the use of an additional instrument cable (non-sterile). An accessory Cannula may be used to facilitate coagulation device access and visibility of the heart. The EPi-Sense Guided Coagulation System with VisiTrax technology is intended for the coagulation of cardiac tissue using Radiofrequency (RF) energy using thoracoscopic, endoscopic, and laparoscopic surgical techniques and may be used for temporary cardiac signal sensing and recording during surgery when connected to a temporary external recording device.
The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1887-2019 |
| Date reported | July 3, 2019 |
| Date initiated | May 29, 2019 |
| Recalling firm | AtriCure, Inc. |
| Firm location | Mason, OH |
| Affected scope | 497 |
| Distribution | Worldwide distribution - US Nationwide distribution, and countries of Germany and Netherlands. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 40909 other recalls in this category.
Boston Scientific Corporation · 2026-07-29
Boston Scientific Corporation · 2026-07-29
AVID Medical, Inc. · 2026-07-29
Penumbra, Inc. · 2026-07-29
Alphatec Spine, Inc. · 2026-07-29
Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported July 3, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.